RUO‘ZENLog in
Stocks › Healthcare › PHVS

Pharvaris stockPHVS

Pharvaris NV · Nasdaq
$32.53
−5.24% on the day
close Nov 5, 2026
What is happening with the stock

Pharvaris trades at $32.53, 24.8% below its 52-week high (Sep 8, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +17.2% year to date, +49.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 18, 2026.

Closing price, 6 monthsdetailed chart in the terminal
27.1933.2239.2552-week high 43.25 — above the chartMay 8, 2026Nov 5, 2026

Ratings, candles, signals and the screener for PHVS — after you log in

Open the terminal
From 52-week high−24.8%
High43.25 Sep 8, 2026
vs 50-day avg−2.6%
vs 200-day avg+4.4%
Year to date+17.2%
12 months+49.8%
Dividend yieldnone
EarningsNov 18
Market cap$2.3B
Chart patternconsolidation
Exchange · sinceNasdaq · 2021

Frequently asked questions about Pharvaris

What is the Pharvaris stock price?

At the close on Nov 5, 2026: $32.53 (−5.24% on the day). 52-week high: $43.25 on Sep 8, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Pharvaris report earnings?

The next quarterly report is on Nov 18, 2026. Last quarter, earnings per share changed +17% year over year, revenue 0%.

Does Pharvaris pay dividends?

No, Pharvaris does not pay dividends.

Where does Pharvaris trade and how to buy it?

Ticker PHVS, exchange Nasdaq, listed since 2021. You can buy it through a broker with access to US exchanges.

Should I buy Pharvaris now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for PHVS are in the terminal after you log in.

Similar stocks

More on PHVS

Included in lists